Sophia Net Income From Continuing Ops from 2010 to 2026
| SOPH Stock | USD 5.32 0.04 0.75% |
Net Loss | First Reported 2020-06-30 | Previous Quarter -22.4 M | Current Value -20 M | Quarterly Volatility 5.1 M |
Check Sophia Genetics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Sophia Genetics' main balance sheet or income statement drivers, such as Tax Provision of 1.5 M, Net Interest Income of 1.7 M or Interest Income of 4.1 M, as well as many indicators such as Price To Sales Ratio of 3.39, Dividend Yield of 0.0 or PTB Ratio of 2.29. Sophia financial statements analysis is a perfect complement when working with Sophia Genetics Valuation or Volatility modules.
Sophia | Net Income From Continuing Ops | Build AI portfolio with Sophia Stock |
Latest Sophia Genetics' Net Income From Continuing Ops Growth Pattern
Below is the plot of the Net Income From Continuing Ops of Sophia Genetics SA over the last few years. It is Sophia Genetics' Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Sophia Genetics' overall financial position and show how it may be relating to other accounts over time.
| Net Income From Continuing Ops | 10 Years Trend |
|
Net Income From Continuing Ops |
| Timeline |
Sophia Net Income From Continuing Ops Regression Statistics
| Arithmetic Mean | (46,773,329) | |
| Coefficient Of Variation | (40.15) | |
| Mean Deviation | 16,147,955 | |
| Median | (33,791,000) | |
| Standard Deviation | 18,781,439 | |
| Sample Variance | 352.7T | |
| Range | 53.7M | |
| R-Value | (0.73) | |
| Mean Square Error | 177.5T | |
| R-Squared | 0.53 | |
| Significance | 0.001 | |
| Slope | (2,703,015) | |
| Total Sum of Squares | 5643.9T |
Sophia Net Income From Continuing Ops History
About Sophia Genetics Financial Statements
Investors use fundamental indicators, such as Sophia Genetics' Net Income From Continuing Ops, to determine how well the company is positioned to perform in the future. Although Sophia Genetics' investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
| Last Reported | Projected for Next Year | ||
| Net Loss | -56.2 M | -59.1 M |
Currently Active Assets on Macroaxis
When determining whether Sophia Genetics SA offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Sophia Genetics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Sophia Genetics Sa Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Sophia Genetics Sa Stock:Check out the analysis of Sophia Genetics Correlation against competitors. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sophia Genetics. If investors know Sophia will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sophia Genetics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.12) | Revenue Per Share | Quarterly Revenue Growth 0.228 | Return On Assets | Return On Equity |
The market value of Sophia Genetics SA is measured differently than its book value, which is the value of Sophia that is recorded on the company's balance sheet. Investors also form their own opinion of Sophia Genetics' value that differs from its market value or its book value, called intrinsic value, which is Sophia Genetics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sophia Genetics' market value can be influenced by many factors that don't directly affect Sophia Genetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sophia Genetics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Sophia Genetics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sophia Genetics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.